BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 37996128)

  • 1. CAR T cells for treating autoimmune diseases.
    Blache U; Tretbar S; Koehl U; Mougiakakos D; Fricke S
    RMD Open; 2023 Nov; 9(4):. PubMed ID: 37996128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chimeric Antigen Receptor Based Therapy as a Potential Approach in Autoimmune Diseases: How Close Are We to the Treatment?
    Sadeqi Nezhad M; Seifalian A; Bagheri N; Yaghoubi S; Karimi MH; Adbollahpour-Alitappeh M
    Front Immunol; 2020; 11():603237. PubMed ID: 33324420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CAR T-cell therapy in autoimmune diseases.
    Schett G; Mackensen A; Mougiakakos D
    Lancet; 2023 Nov; 402(10416):2034-2044. PubMed ID: 37748491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoimmunity as a target for chimeric immune receptor therapy: A new vision to therapeutic potential.
    Haddadi MH; Hajizadeh-Saffar E; Khosravi-Maharlooei M; Basiri M; Negahdari B; Baharvand H
    Blood Rev; 2020 May; 41():100645. PubMed ID: 31813654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dawn of CAR-T cell therapy in autoimmune diseases.
    Liu Y; Dong M; Chu Y; Zhou L; You Y; Pang X; Yang S; Zhang L; Chen L; Zhu L; Xiao J; Wang W; Qin C; Tian D
    Chin Med J (Engl); 2024 May; 137(10):1140-1150. PubMed ID: 38613216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expanding the role of CAR T-cell therapy: From B-cell hematological malignancies to autoimmune rheumatic diseases.
    Shumnalieva R; Velikova T; Monov S
    Int J Rheum Dis; 2024 May; 27(5):e15182. PubMed ID: 38742463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CARs: a new approach for the treatment of autoimmune diseases.
    Sun Y; Yuan Y; Zhang B; Zhang X
    Sci China Life Sci; 2023 Apr; 66(4):711-728. PubMed ID: 36346550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is There a Place for Chimeric Antigen Receptor-T Cells in the Treatment of Chronic Autoimmune Rheumatic Diseases?
    Orvain C; Boulch M; Bousso P; Allanore Y; Avouac J
    Arthritis Rheumatol; 2021 Nov; 73(11):1954-1965. PubMed ID: 34042325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are chimeric antigen receptor T cells (CAR-T cells) the future in immunotherapy for autoimmune diseases?
    Santamaria-Alza Y; Vasquez G
    Inflamm Res; 2021 Jun; 70(6):651-663. PubMed ID: 34018005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The making and function of CAR cells.
    Zabel M; Tauber PA; Pickl WF
    Immunol Lett; 2019 Aug; 212():53-69. PubMed ID: 31181279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Research Techniques Made Simple: CAR T-Cell Therapy.
    Siddiqi HF; Staser KW; Nambudiri VE
    J Invest Dermatol; 2018 Dec; 138(12):2501-2504.e1. PubMed ID: 30243656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CAR T cell immunotherapy in hematology and beyond.
    Rossig C
    Clin Immunol; 2018 Jan; 186():54-58. PubMed ID: 28923441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chimeric antigen receptor T cell therapy: a new emerging landscape in autoimmune rheumatic diseases.
    Lyu X; Gupta L; Tholouli E; Chinoy H
    Rheumatology (Oxford); 2024 May; 63(5):1206-1216. PubMed ID: 37982747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD8
    Whittington KB; Prislovsky A; Beaty J; Albritton L; Radic M; Rosloniec EF
    J Immunol; 2022 Jan; 208(1):16-26. PubMed ID: 34819392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Harnessing the inherent power of chimeric antigen receptor (CAR)-expressing regulatory T cells (CAR-Tregs) to treat autoimmune-related disorders.
    Kahmini FR; Shahgaldi S
    Mol Biol Rep; 2022 May; 49(5):4069-4078. PubMed ID: 35534581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chimeric antigen receptors: "CARs" in the fast lane for rheumatology.
    Johnson NM; Koumpouras F
    Curr Opin Rheumatol; 2024 May; 36(3):176-183. PubMed ID: 38517338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B cell-targeting chimeric antigen receptor T cells as an emerging therapy in neuroimmunological diseases.
    Haghikia A; Schett G; Mougiakakos D
    Lancet Neurol; 2024 Jun; 23(6):615-624. PubMed ID: 38760099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical practice: chimeric antigen receptor (CAR) T cells: a major breakthrough in the battle against cancer.
    Lundh S; Jung IY; Dimitri A; Vora A; Melenhorst JJ; Jadlowsky JK; Fraietta JA
    Clin Exp Med; 2020 Nov; 20(4):469-480. PubMed ID: 32333215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of CAR-T cell technology in autoimmune diseases and human immunodeficiency virus infection treatment.
    Adabi N; Pordel S; Rezaee MA; Shobeiri FS; Shobeiri SS
    J Gene Med; 2023 May; 25(5):e3484. PubMed ID: 36781390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The UniCAR system: A modular CAR T cell approach to improve the safety of CAR T cells.
    Bachmann M
    Immunol Lett; 2019 Jul; 211():13-22. PubMed ID: 31091431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.